Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03261180

Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer

Perioperative Nutritional Optimization in Head and Neck Cancer Patients

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized clinical trial studies how well Nestle Impact Advanced Recovery works in improving surgery recovery in patients with head and neck cancer. Adding a nutritional supplement, such as Nestle Impact Advanced Recovery to a regular diet before and after head and neck cancer surgery may help to decrease the number of wound complications after surgery.

Detailed description

PRIMARY OBJECTIVES: I. Assess the effect of perioperative use of Nestle Impact Advanced Recovery (AR) on the rate of post-operative wound complications within 30 days after major head and neck surgery. SECONDARY OBJECTIVES: I. Assess whether sarcopenia is an independent risk factor for the development of post-operative wound complications. II. Assess whether Nestle IMPACT AR decreases the rate of other post-operative complications such as pneumonia, urinary tract infection, deep vein thrombosis, and clostridium difficile colitis within 30 days of surgery, as well as length of hospital stay. TERTIARY OBJECTIVES: I. Assess changes in muscle metabolic gene expression at the time of surgery associated with sarcopenia and IMAPCT treatment. OUTLINE: Patients are randomized into 1 of 2 groups. GROUP I: Patients receive Nestle Impact AR for 5 days before and after surgery in addition to regular diet. GROUP I: Patients receive regular diet. After completion of study, patients are followed up for 30 days post-surgery.

Conditions

Interventions

TypeNameDescription
OTHERBest PracticeReceive regular diet
OTHERLaboratory Biomarker AnalysisCorrelative studies
DIETARY_SUPPLEMENTNutritional InterventionReceive Nestle Impact AR

Timeline

Start date
2017-11-30
Primary completion
2020-08-10
Completion
2021-08-09
First posted
2017-08-24
Last updated
2020-02-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03261180. Inclusion in this directory is not an endorsement.